We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCL icon
76
Carnival Corporation Ltd
CCL
$39.7B
$171M 0.24%
3,900,842
+290,927
+8% +$13.4M
ABT icon
77
Abbott
ABT
$187B
$166M 0.23%
1,983,959
+50,122
+3% +$4.26M
RSP icon
78
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$165M 0.23%
1,525,549
-28,947
-2% -$3.11M
COST icon
79
Costco
COST
$420B
$165M 0.23%
571,888
+66,063
+13% +$18.6M
IWM icon
80
iShares Russell 2000 ETF
IWM
$83B
$161M 0.22%
1,065,371
-100,409
-9% -$15.3M
TXN icon
81
Texas Instruments
TXN
$261B
$160M 0.22%
1,240,761
+381,476
+44% +$47M
PM icon
82
Philip Morris
PM
$295B
$160M 0.22%
2,110,542
-242,254
-10% -$19.2M
PNC icon
83
PNC Financial Services
PNC
$101B
$159M 0.22%
1,132,728
+33,549
+3% +$4.55M
TGT icon
84
Target
TGT
$68B
$156M 0.22%
1,458,807
+45,873
+3% +$4.36M
VEA icon
85
Vanguard FTSE Developed Markets ETF
VEA
$236B
$154M 0.22%
3,753,566
+133,110
+4% +$5.44M
AMGN icon
86
Amgen
AMGN
$222B
$153M 0.21%
788,961
-725
-0.1% -$139K
USB icon
87
US Bancorp
USB
$99.6B
$149M 0.21%
2,700,196
+13,764
+0.5% +$744K
NEE icon
88
NextEra Energy
NEE
$177B
$148M 0.21%
2,542,588
+70,660
+3% +$3.82M
BDX icon
89
Becton Dickinson
BDX
$48.2B
$148M 0.21%
599,403
+25,392
+4% +$6.27M
XLK icon
90
State Street Technology Select Sector SPDR ETF
XLK
$124B
$147M 0.2%
3,648,830
+285,820
+8% +$11.4M
GSK icon
91
GSK
GSK
$106B
$147M 0.2%
2,746,916
-140,265
-5% -$7.22M
GSLC icon
92
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
$146M 0.2%
2,438,934
+180,943
+8% +$10.8M
VIG icon
93
Vanguard Dividend Appreciation ETF
VIG
$114B
$145M 0.2%
1,208,854
+66,121
+6% +$7.8M
IBM icon
94
IBM
IBM
$224B
$143M 0.2%
1,031,077
+119,053
+13% +$16.1M
RTX icon
95
RTX Corp
RTX
$301B
$142M 0.2%
1,656,631
+48,275
+3% +$4.01M
FVD icon
96
First Trust Value Line Dividend Fund
FVD
$8.41B
$140M 0.2%
4,016,997
+517,606
+15% +$17.6M
TTE icon
97
TotalEnergies
TTE
$190B
$137M 0.19%
2,631,819
-74,374
-3% -$3.86M
EFA icon
98
iShares MSCI EAFE ETF
EFA
$80.2B
$137M 0.19%
2,095,873
+216,984
+12% +$14M
BCE icon
99
BCE
BCE
$21.2B
$133M 0.19%
2,756,317
-87,463
-3% -$4.09M
TFC icon
100
Truist Financial
TFC
$64B
$133M 0.19%
2,495,727
+52,667
+2% +$2.61M

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.